Completed PHASE4 INTERVENTIONAL 2-arm NCT01559753

Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment

Comparison of Two Lengths of Treatment in Early-onset Ventilated Associated Pneumonia

Sponsor: Centre Hospitalier Universitaire de Besancon

Conditions Pneumonia Ventilator Associated

Interventions Augmentin, Ceftriaxone, Cefotaxime, netilmycin, tobramycin compare 8 to15 days of antibiotic treatment

Updated 5 times since 2017 Last updated: Mar 19, 2012 Started: Jan 31, 1998 Primary completion: Sep 30, 2002 Completion: Nov 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01559753, this PHASE4 trial focuses on Pneumonia Ventilator Associated and remains completed. Sponsored by Centre Hospitalier Universitaire de Besancon, it has been updated 5 times since 1998, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Besancon
French Society for Intensive Care
GlaxoSmithKline
SmithKline Beecham

Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.